ZA841766B - Use of pyrazolone derivatives as lipoxygenase inhibitors in the therapy of ischaemias and disorders in cardiac rhythm,inflammations of the skin and eye,and of rheumatic,allergic and asthmatic diseases,oedemas,pulmonary embolisms,pulmonary hypertension,shock lung,oxygen intoxication and ulcerations,medicaments for this therapy and processes for their preparation - Google Patents

Use of pyrazolone derivatives as lipoxygenase inhibitors in the therapy of ischaemias and disorders in cardiac rhythm,inflammations of the skin and eye,and of rheumatic,allergic and asthmatic diseases,oedemas,pulmonary embolisms,pulmonary hypertension,shock lung,oxygen intoxication and ulcerations,medicaments for this therapy and processes for their preparation

Info

Publication number
ZA841766B
ZA841766B ZA841766A ZA841766A ZA841766B ZA 841766 B ZA841766 B ZA 841766B ZA 841766 A ZA841766 A ZA 841766A ZA 841766 A ZA841766 A ZA 841766A ZA 841766 B ZA841766 B ZA 841766B
Authority
ZA
South Africa
Prior art keywords
therapy
pulmonary
oedemas
ischaemias
ulcerations
Prior art date
Application number
ZA841766A
Other languages
English (en)
Inventor
Mithat Mardin
Friedel Seuter
Elisabeth Perzborn
Klaus Schlossmann
Dieter Mayer
Volker Fiedler
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA841766B publication Critical patent/ZA841766B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA841766A 1983-03-12 1984-03-09 Use of pyrazolone derivatives as lipoxygenase inhibitors in the therapy of ischaemias and disorders in cardiac rhythm,inflammations of the skin and eye,and of rheumatic,allergic and asthmatic diseases,oedemas,pulmonary embolisms,pulmonary hypertension,shock lung,oxygen intoxication and ulcerations,medicaments for this therapy and processes for their preparation ZA841766B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833308881 DE3308881A1 (de) 1983-03-12 1983-03-12 Verwendung von pyrazolonderivaten als lipoxygenasehemmer, bei der therapie von ischaemien und herzrhythmusstoerungen sowie von rheumatischen, allergischen und asthmatischen erkrankungen, oedemen, lungenembolien, pulmonaler hypertension, sauerstoffintoxikation und ulcerationen, arzneimittel hierfuer und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
ZA841766B true ZA841766B (en) 1984-10-31

Family

ID=6193304

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA841766A ZA841766B (en) 1983-03-12 1984-03-09 Use of pyrazolone derivatives as lipoxygenase inhibitors in the therapy of ischaemias and disorders in cardiac rhythm,inflammations of the skin and eye,and of rheumatic,allergic and asthmatic diseases,oedemas,pulmonary embolisms,pulmonary hypertension,shock lung,oxygen intoxication and ulcerations,medicaments for this therapy and processes for their preparation

Country Status (4)

Country Link
JP (1) JPS59175469A (de)
KR (1) KR840008326A (de)
DE (1) DE3308881A1 (de)
ZA (1) ZA841766B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE35801E (en) * 1985-05-20 1998-05-19 Mitsubishi Chemical Corporation Prophylactic and therapeutic composition for circulatory disorders and method of treatment
US4970210A (en) * 1987-07-17 1990-11-13 Abbott Laboratories Triazinone lipoxygenase compounds
WO2009067343A1 (en) * 2007-11-21 2009-05-28 Teikoku Pharma Usa, Inc. Pyrazolone derivative emulsion formulations

Also Published As

Publication number Publication date
DE3308881A1 (de) 1984-09-13
JPS59175469A (ja) 1984-10-04
KR840008326A (ko) 1984-12-14

Similar Documents

Publication Publication Date Title
Gueron et al. Severe myocardial damage and heart failure in scorpion sting: Report of five cases
EP0200406A3 (de) Aminosäurederivate
CA2141572A1 (en) Terfenadine Metabolites and Their Optically Pure Isomers for Treating Allergic Disorders
CA2137237A1 (en) Purified forms of dnase
EP0149242A3 (en) 1-(2-hydroxyaryl)-alcan-1-one oxime, preparation and pharmaceutical use
CA2143610A1 (en) Use of norastemizole for the treatment of allergic disorders
DE3062981D1 (en) Alkyl-urea derivatives for the treatment of lipometabolic diseases; process for their preparation, their use in medicaments for the treatment of lipometabolic disorders, medicaments containing them, process for the preparation of the medicaments, and some alkyl-urea derivatives
EP0190891A3 (de) Aminosäurederivate
PT78239B (en) Process for preparing medicaments based on pyrazolone derivatives and process for using them as lipoxygenase inhibitors in the therapy of ischaemias and disorders in cardiac rhytm inflammations of the skin and eye and of rheumatic allergic and asthmatic diseases oedemas pulmonary embolisms pulmonary hypertension shock lung oxygen intoxication and ulcerations
ZA841766B (en) Use of pyrazolone derivatives as lipoxygenase inhibitors in the therapy of ischaemias and disorders in cardiac rhythm,inflammations of the skin and eye,and of rheumatic,allergic and asthmatic diseases,oedemas,pulmonary embolisms,pulmonary hypertension,shock lung,oxygen intoxication and ulcerations,medicaments for this therapy and processes for their preparation
Isaac The “gauntlet” of pellagra
US4847283A (en) Ointment and method for treating skin lesions due to herpes virus
Kehl Dupuytren's contracture as a sequel to coronary artery disease and myocardial infarction
ZA84637B (en) Use of nafazatrom for the therapy of ischaemias,disorders in cardiac rhythm;inflammations of eye and skin;rheumatic,allergic and asthmatic diseases,ards;pulmonary embolisms;oedemes;pulmonary hypertension;oxygen intoxication;and ulcerations
EP0345028A3 (de) Verwendung eines Phosphodiesterase-Inhibitors zur Glaukombehandlung
ES8500055A1 (es) Procedimiento para la obtencion de un medicamento a base de un derivado de pirazolinona.
WOLINTZ et al. Stokes-Adams syndrome and atrial arrhythmias as the presenting symptoms of myotonic dystrophy, with response to electrocardioversion
NO971453D0 (no) Anvendelse av bradykinin-antagonister for fremstilling av legemidler for behandling av kroniske fibrogenetiske og akutte leversykdommer
AU516531B2 (en) Method and composition forthe therapy of cerebral circulatory diseases
JPS5585526A (en) Remedy for allergic disease
von Dohlen et al. Presyncope and syncope: how to find the cause and avoid staggering costs
Gole et al. Familial exudative vitreoretinopathy.
BG102678A (en) 1,4-dihydropyridine compounds as bradykinin antagonists
Miller The effect of the pneumatic antishock garment (PASG) on hemodynamics, hemorrhage, and survival in penetrating thoracic aortic injury: Ali J, Vanderby B, Purcell CJ Trauma 31: 846–851 Jun 1991
IT8348873A0 (it) Retinoprotettore per la terapia del le emorragie intraoculari, delle distrofie corioretiniche, di carattere miopico, delle distropie eredita rie della retina e delle scottature della retina, nonche' per la cura profilattica delle lesioni dovute alla coagulazione a laser